Dohj LLC Lowers Position in MetLife, Inc. (NYSE:MET)

Dohj LLC lessened its position in MetLife, Inc. (NYSE:METFree Report) by 26.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,446 shares of the financial services provider’s stock after selling 3,107 shares during the quarter. Dohj LLC’s holdings in MetLife were worth $559,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the stock. Eley Financial Management Inc raised its stake in MetLife by 1.0% during the third quarter. Eley Financial Management Inc now owns 16,348 shares of the financial services provider’s stock valued at $1,028,000 after buying an additional 168 shares during the last quarter. Austin Private Wealth LLC raised its stake in MetLife by 4.1% during the fourth quarter. Austin Private Wealth LLC now owns 4,367 shares of the financial services provider’s stock valued at $289,000 after buying an additional 170 shares during the last quarter. KLCM Advisors Inc. raised its stake in MetLife by 3.6% during the third quarter. KLCM Advisors Inc. now owns 4,920 shares of the financial services provider’s stock valued at $310,000 after buying an additional 171 shares during the last quarter. Highland Capital Management LLC raised its stake in MetLife by 0.3% during the fourth quarter. Highland Capital Management LLC now owns 61,738 shares of the financial services provider’s stock valued at $4,083,000 after buying an additional 180 shares during the last quarter. Finally, RFG Advisory LLC increased its holdings in shares of MetLife by 3.2% in the 4th quarter. RFG Advisory LLC now owns 5,924 shares of the financial services provider’s stock worth $392,000 after purchasing an additional 181 shares in the last quarter. Hedge funds and other institutional investors own 89.81% of the company’s stock.

MetLife Stock Performance

NYSE:MET traded down $1.48 during mid-day trading on Friday, hitting $70.42. 5,650,572 shares of the company traded hands, compared to its average volume of 2,506,510. The stock’s fifty day moving average price is $71.44 and its 200-day moving average price is $67.19. MetLife, Inc. has a one year low of $48.95 and a one year high of $74.68. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.53. The firm has a market cap of $50.92 billion, a price-to-earnings ratio of 38.48, a price-to-earnings-growth ratio of 0.53 and a beta of 1.04.

MetLife (NYSE:METGet Free Report) last released its quarterly earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.95 by ($0.02). MetLife had a net margin of 2.36% and a return on equity of 19.48%. The company had revenue of $18.72 billion for the quarter, compared to the consensus estimate of $18.07 billion. Research analysts anticipate that MetLife, Inc. will post 8.71 earnings per share for the current fiscal year.

MetLife Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 11th. Shareholders of record on Tuesday, May 7th will be issued a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 3.10%. The ex-dividend date of this dividend is Monday, May 6th. This is a positive change from MetLife’s previous quarterly dividend of $0.52. MetLife’s payout ratio is currently 113.66%.

Analyst Ratings Changes

A number of analysts have commented on the company. The Goldman Sachs Group raised MetLife from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $70.00 to $80.00 in a report on Monday, January 8th. Wells Fargo & Company lifted their target price on MetLife from $83.00 to $86.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. Keefe, Bruyette & Woods lifted their target price on MetLife from $82.00 to $87.00 and gave the stock an “outperform” rating in a report on Wednesday, April 10th. UBS Group reduced their target price on MetLife from $87.00 to $82.00 and set a “buy” rating for the company in a report on Monday, February 5th. Finally, Morgan Stanley lifted their price objective on MetLife from $80.00 to $82.00 and gave the stock an “overweight” rating in a report on Monday, April 15th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $79.23.

Read Our Latest Stock Analysis on MetLife

Insider Buying and Selling at MetLife

In other news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the transaction, the insider now directly owns 146,981 shares in the company, valued at $10,567,933.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the transaction, the insider now directly owns 146,981 shares in the company, valued at $10,567,933.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the completion of the transaction, the executive vice president now owns 57,768 shares in the company, valued at $4,174,893.36. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by corporate insiders.

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.